MBX Biosciences GAAP EPS of -$0.78 (MBX:NASDAQ)
· seekingalpha.com
MBX Biosciences (MBX) Q2 update: GAAP EPS -$0.78, $418.6M cash, runway into 2029, net loss widened to $37.1M.
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
If you have an ad-blocker enabled you may be blocked from ...